222 related articles for article (PubMed ID: 7191289)
21. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
Chan TK; Chan V
Thromb Haemost; 1981 Aug; 46(2):504-6. PubMed ID: 7302889
[TBL] [Abstract][Full Text] [Related]
22. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
23. [The determination of heparin].
Aiach M
Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
[No Abstract] [Full Text] [Related]
24. Measurement of the heparin neutralizing capacity of protamine.
Graham DT; Pomeroy AR; Smythe DB
Thromb Haemost; 1979 May; 41(3):583-9. PubMed ID: 462424
[TBL] [Abstract][Full Text] [Related]
25. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
Bhargava AS; Freihube G; Günzel P
Arzneimittelforschung; 1980; 30(10):1621-3. PubMed ID: 7192096
[TBL] [Abstract][Full Text] [Related]
27. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma.
Andersson LO; Barrowcliffe TW; Holmer E; Johnson EA; Söderström G
Thromb Res; 1979; 15(3-4):531-41. PubMed ID: 494159
[No Abstract] [Full Text] [Related]
28. Relative activities of heparin fractions obtained by gel chromatography.
Graham DT; Pomeroy AR
Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
[TBL] [Abstract][Full Text] [Related]
29. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
Kitchen S; Theaker J; Preston FE
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
[TBL] [Abstract][Full Text] [Related]
30. Interaction of heparin with lipoproteins - role of the complex in the inactivation of thrombin and plasmin.
Kecskés E; Büki KG; Bauer PI; Machovich R; Horváth I
Thromb Haemost; 1983 Apr; 49(2):138-41. PubMed ID: 6223404
[TBL] [Abstract][Full Text] [Related]
31. In vivo neutralization of low-molecular weight heparin fraction CY 216 by protamine.
Doutremépuich C; Bonini F; Toulemonde F; Bertrand H; Bayrou B; Quilichini R
Semin Thromb Hemost; 1985 Jul; 11(3):318-22. PubMed ID: 4048954
[TBL] [Abstract][Full Text] [Related]
32. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
[TBL] [Abstract][Full Text] [Related]
33. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
[TBL] [Abstract][Full Text] [Related]
34. Pre-clinical pharmacological profile of the novel glycoconjugate Org 36764 with both factor Xa and thrombin (IIa) inhibitory activities.
Vogel GM; van Amsterdam RG; van Dinther TG; Tromp M; Meuleman DG
Thromb Haemost; 2000 Oct; 84(4):611-20. PubMed ID: 11057859
[TBL] [Abstract][Full Text] [Related]
35. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
36. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
[TBL] [Abstract][Full Text] [Related]
37. Effect of protamine sulfate on antithrombin III activity.
Matsuo T; Shanberge JN; Matsuo O
Clin Chim Acta; 1983 Jul; 131(3):233-8. PubMed ID: 6883717
[TBL] [Abstract][Full Text] [Related]
38. Heparinized polyurethanes: in vitro and in vivo studies.
Heyman PW; Cho CS; McRea JC; Olsen DB; Kim SW
J Biomed Mater Res; 1985 Apr; 19(4):419-36. PubMed ID: 4055825
[TBL] [Abstract][Full Text] [Related]
39. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
Ototani N; Kikuchi M; Yosizawa Z
Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory activities for thrombin and factor Xa of whale heparin: comparative studies on two preparations from different species.
Ototani N; Yosizawa Z
Tohoku J Exp Med; 1986 Sep; 150(1):77-82. PubMed ID: 3775773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
